|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Cardiovascular Diseases | |||||
| Heart Diseases | |||||
| Obesity | |||||
| Hypertension | |||||
| Hyperinsulinism | |||||
| Insulin Resistance | |||||
| Metabolic Syndrome X | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Body Weight | |||||
| Disease | |||||
| Glucose Metabolism Disorders | |||||
| Metabolic Diseases | |||||
| Nutrition Disorders | |||||
| Overnutrition | |||||
| Overweight | |||||
| Pathologic Processes | |||||
| Signs and Symptoms | |||||
| Vascular Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| National Heart, Lung, and Blood Institute (NHLBI) | |||||